Balancing N-linked glycosylation to avoid disease (Q26810044)

ORCID Public Data File 2021

Europe PubMed Central

title

Balancing N-linked glycosylation to avoid disease (English)

0 references

0 references

1 reference

1 reference

author name string

H H Freeze

series ordinal

1

0 references

V Westphal

series ordinal

2

0 references

language of work or name

English

0 references

publication date

August 2001

0 references

published in

Biochimie

0 references

volume

83

0 references

page(s)

791-9

0 references

issue

8

0 references

cites work

Congenital disorders of glycosylation: glycosylation defects in man and biological models for their study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Congenital disorders of glycosylation: genetic model systems lead the way.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Congenital disorders of glycosylation: have you encountered them?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The frequency and origin of the sickle cell mutation in the district of Coruche/Portugal

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Hypothesis: a selective advantage for cystic fibrosis heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

A selective advantage for cystic fibrosis carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The dolichol pathway of N-linked glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Protein translocation into the endoplasmic reticulum (ER)--two similar routes with different modes.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Transport of proteins across the endoplasmic reticulum membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Protein glycosylation in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Assembly of asparagine-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The quality control of glycoprotein folding in the endoplasmic reticulum, a trip from trypanosomes to mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Quality control in the secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Setting the standards: quality control in the secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Glycosylation efficiency of Asn-Xaa-Thr sequons depends both on the distance from the C terminus and on the presence of a downstream transmembrane segment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Biological roles of oligosaccharides: all of the theories are correct

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Expression of dolichol-linked saccharide intermediate synthesis during the development of B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Mutants in dolichol synthesis: conversion of polyprenol to dolichol appears to be a rate-limiting step in dolichol synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Synthesis of lipid-linked oligosaccharides is dependent on the cell cycle in rat 3Y1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Effect of ethanol administration on the level of dolichol in rat liver microsomes and Golgi apparatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Long-term ethanol exposure impairs glycosylation of both N- and O-glycosylated proteins in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Possible reasons why heavy drinking increases carbohydrate-deficient transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Carbohydrate-deficient transferrin in healthy women: relation to estrogens and iron status.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Increased carbohydrate-deficient transferrin during pregnancy: relation to sex hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Catabolic pathway of oligosaccharide-diphospho-dolichol. Subcellular sites of the degradation of the oligomannoside moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

'Glyco-deglyco' processes during the synthesis of N-glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Transport of free and N-linked oligomannoside species across the rough endoplasmic reticulum membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Trafficking of oligomannosides released during N-glycosylation: a clearing mechanism of the rough endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Intracellular functions of N-linked glycans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Translation rate of human tyrosinase determines its N-linked glycosylation level

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Truncated profibrillin of a Marfan patient is of apparent similar size as fibrillin: intracellular retention leads to over-N-glycosylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Cutting Edge: Granzyme B Proteolysis of a Neuronal Glutamate Receptor Generates an Autoantigen and Is Modulated by Glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Defective glycosyltransferases are not good for your health.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Direct utilization of mannose for mammalian glycoprotein biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with Congenital Disorders of Glycosylation (CDG)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Human glycosylation disorders and sugar supplement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Requirement of the Lec35 gene for all known classes of monosaccharide-P-dolichol-dependent glycosyltransferase reactions in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Stepwise assembly of the lipid-linked oligosaccharide in the endoplasmic reticulum of Saccharomyces cerevisiae: identification of the ALG9 gene encoding a putative mannosyl transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Molecular heterosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The role of N-linked glycosylation in the secretion of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Glycosylation and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Searching for medicine's sweet spot

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

α-Glucosidase inhibitors as potential broad based anti-viral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Expression of rabies virus glycoprotein from a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The ascension of wildlife rabies: a cause for public health concern or intervention?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

The relative power of SNPs and haplotype as genetic markers for association tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Association study designs for complex diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021

Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901292-5

7 January 2021